According to her claim, switching to another GLP-1 medication did not resolve her condition
Lahiri S, Kim H, Garcia-Perez I, Reza MM, Martin KA, Kundu P, et al
To increase the therapeutic effectiveness of GLP-1 in people with type 2 diabetes mellitus (T2DM), attempts have been made to prolong its half-life in the body
However you slice it, sugar reduction is here to stay. Sugar reduction technologies here to stay, but likely to evolve Sugar reduction trends come and go and one of the latest to enter the scene is actually no sugar reduction at all
Blood Sugar Regulation: Originally developed for type 2 diabetes, these drugs also stimulate the pancreas to release insulin appropriately in response to rising blood sugar levels after meals and suppress the release of glucagon (a hormone that raises blood sugar) when levels are high
Physical evidence, purchase records, and injury documentation all play a role in connecting the defect to the harm